Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT05439057
Eligibility Criteria:
Inclusion Criteria:
* women undergoing laparoscopic cholecystectomy under general anesthesia.
Exclusion Criteria:
* moderate to severe liver dysfunction (total bilirubin ≧ 3.0 mg/dL / aspartate aminotransferase(AST) or alanine aminotransferase(ALT) ≧ 2.5 times more than normal range)
* moderate to severe renal dysfunction (serum creatinine ≧ 2.0 mg/dL / end-stage renal disease undergoing hemodialysis)
* tolerance to benzodiazepines
* hypersensitivity to anesthetic drugs (Benzodiazepines, Propofol, Remifentanil, Fentanyl citrate, Rocuronium bromide, Flumazenil)
* acute angle glaucoma
* alcohol dependence
* Galactose intolerance, Lactase deficiency, glucose-galactose malabsorption
* pregnant, breast feeding women
* BMI \>35 kg/m2
* uncontrolled diabetes mellitus
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
19 Years
Maximum Age:
65 Years
Study:
NCT05439057
Study Brief:
Protocol Section:
NCT05439057